Adaptimmune Therapeutics PLC 4
4 · Adaptimmune Therapeutics PLC · Filed Jul 3, 2017
Insider Transaction Report
Form 4
Kerr Giles Francis Bertram
Director
Transactions
- Award
Option to purchase Ordinary Shares
2017-07-03+144,000→ 144,000 totalExercise: $0.75From: 2018-07-03Exp: 2027-07-03→ Ordinary Shares (144,000 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.58 based on the closing midpoint exchange rate for the U.S. dollar on the trading day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount.